Disclosed positions

Estimated from their latest filings — positions may have changed since

$188.9K

combined est. value

Stock	Shares	Price	Value	Weight	As of
MLYSMineralys Therapeutics, Inc.	6,200	$30.46	$188.9K	100%	2026-06-17

MLYS

Mineralys Therapeutics, Inc.

$188.9K

6,200 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 3

Stock	Transaction	Date	~6mo later
MLYSMineralys Therapeutics, Inc.	Sell $75.0K · 3,000 sh	2026-06-17	—
MLYSMineralys Therapeutics, Inc.	Exercise $36.1K · 3,000 sh	2026-06-17	—
MLYSMineralys Therapeutics, Inc.	Grant — · 6,200 sh	2026-02-19	—
MLYSMineralys Therapeutics, Inc.	Sell $226.4K · 4,885 sh	2025-11-13	—
MLYSMineralys Therapeutics, Inc.	Sell $463.4K · 10,115 sh	2025-11-13	—
MLYSMineralys Therapeutics, Inc.	Exercise $153.0K · 15,000 sh	2025-11-13	—

MLYSSell

2026-06-17 · Mineralys Therapeutics, Inc.

$75.0K

—

MLYSExercise

2026-06-17 · Mineralys Therapeutics, Inc.

$36.1K

—

MLYSGrant

2026-02-19 · Mineralys Therapeutics, Inc.

6,200

—

MLYSSell

2025-11-13 · Mineralys Therapeutics, Inc.

$226.4K

—

MLYSSell

2025-11-13 · Mineralys Therapeutics, Inc.

$463.4K

—

MLYSExercise

2025-11-13 · Mineralys Therapeutics, Inc.

$153.0K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.